Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells.
Journal Information
Full Title: Mol Metab
Abbreviation: Mol Metab
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"data availability i have attached the raw data as supplementary material appendix a supplementary data to this article can be found online at https://doi"
"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
"This research was funded by The Swedish Cancer Foundation (Cancerfonden), grant numbers 20 1076PjF, 20 0175 F, and CAN2018/602; The Swedish Society for Medical Research (SSMF), grant number S17-0092; The Swedish Research Council (Vetenskapsrådet), grant numbers 2018-03301 and 2020-02367, and the Göran Gustafsson foundation. None of the funders have played a role in study design, collection, analyses and interpretation of data, writing or decision to submit this article."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025